Primary aromatic amines: Their N-oxidative bioactivation

Human and Experimental Toxicology

Volumn 16, Issue 8, 1997, Pages 441-448

  Hlavica, P ^a   Golly, I ^b   Lehnerer, M ^a   Schulze, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Division Hermes Pharma Georg Kalb Strasse   (Germany)

Author keywords

Enzymology; N oxygenation; Primary arylamines; Toxicity

Indexed keywords

AROMATIC AMINE; CHLORIDE PEROXIDASE; CYTOCHROME P450; FREE RADICAL; HEMOGLOBIN; HORSERADISH PEROXIDASE; LACTOPEROXIDASE; MYELOPEROXIDASE; NITROGEN DERIVATIVE; PEROXIDASE; PROSTAGLANDIN SYNTHASE; QUERCETIN; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CATALYSIS; ENZYME ACTIVATION; MAMMAL CELL; OXIDATION; PEROXIDATION; PHOTOLYSIS; PRIORITY JOURNAL;

ARMORACIA RUSTICANA; MAMMALIA; OXY;

EID: 0030854339     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719701600805     Document Type: Article

References (81)

1. Hlavica P. Biological oxidation of nitrogen in organic compounds and disposition of N-oxidized products. CRC Crit Rev Biochem 1982; 12: 39-101.
2. Kiese M. Methemoglobinemia: A Comprehensive Treatise. CRC Press Cleveland, 1974.
3. Uetrecht J. The role of N-oxidation by leucocytes in drug-induced agranulocytosis and other drug hypersensitivity reactions. In: Hlavica P and Damani LA (eds.). N-Oxidation of Drugs. Biochemistry, Pharmacology, Toxicology, Chapman and Hall, London, 1991, pp435-453.
4. Kriek E. Carcinogenesis by aromatic amines. Biochim Biophys Acta 1974; 355: 177-203.
5. Nelson DR et al. The P-450 superfamily: update of new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993; 12: 1-51.
6. Lu AYH, Coon MJ. Role of hemoprotein P-450 in fatty acid ω-hydroxylation in a soluble enzyme system from liver microsomes. J Biol Chem 1968; 243; 1331-1332.
7. 5 on cytochrome P-450-catalyzed reactions. Drug Metab Dispos 1984; 12: 358-364.
8. Heinze E, Hlavica P, Kiese M, Lipowsky G. N-Oxygenation of arylamines in microsomes prepared from corpora lutea of the cycle and other tissues of the pig. Biochem Pharmacol 1970; 19: 641-649.
9. Hlavica P, Kehl M. Studies on the mechanism of hepatic microsomal N-oxide formation. Hoppe-Seyler's Z Physiol Chem 1974; 355: 1508-1514.
10. Uehleke H. N-Hydroxylation. Xenobiotica 1971; 1: 327-338.
11. Hlavica P, Golly I, Mietaschk J. Comparative studies on the cumene hydroperoxide- and NADPH-supported N-oxidation of 4-chloroaniline by cytochrome P-450. Biochem J 1983; 212: 539-547.
12. Hlavica P, Kiese M. N-Oxygenation of N-alkyl- and N,N-dialkylanilines by rabbit liver microsomes. Biochem Pharmacol 1969; 18: 1501-1509.
13. Tyrakowska B, Boeren S, Geurtsen B, Rietjens IMCM. Qualitative and quantitative influences of ortho chlorine substituents on the microsomal metabolism of 4-toludines. Drug Metab Dispos 1993; 21: 508-519.
14. Schmidt HL, Kexel H, Weber N. Mikrosomale Oxydation am Stickstoffatom aromatischer Amine. Biochem Pharmacol 1972; 21: 1641-1648.
15. Uetrecht JP, Sweetman BJ, Woosley RL, Oates JA. Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes. Drug Metab Dispos 1984; 12: 77-81.
16. Budinsky RA et al. The formation of procainamide hydroxylamine by rat and human liver microsomes. Drug Metab Dispos 1987; 15; 37-43.
17. Uehleke H, Tabarelli S. N-Hydroxylation of 4,4′-diaminodiphenylsulphone (dapsone) by liver microsomes, and in dogs and humans. NaunynSchmiedeberg's Arch Pharmacol 1973; 278; 55-68.
18. Uehleke H et al. Der Einfluß von Metyrapon auf verschiedene Typen von mikrosomalen N-Oxidationen. Hoppe-Seyler's Z Physiol Chem 1971; 352: 403-411.
19. Uehleke H, Nestel K. Hydroxylamino- und Nitrosobiphenyl: Biologische Oxydationsprodukte von 4-Aminobiphenyl und Zwischenprodukte der Reduktion von 4-Nitrobiphenyl. Naunyn-Schmiedeberg's Arch Pharmak exp Path 1967; 257: 151-171.
20. Degawa M, Kojima M, Sato Y, Hashimoto Y. Induction of a high spin form of microsomal cytochrome P-448 in rat liver by 4-aminoazobenzene derivatives. Biochem Pharmacol 1986; 35: 3565-3570.
21. 4-Hydroxylation of sulfamethoxazole by cytochrome P-450 of the cytochrome P-450 2C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos 1995; 23: 406-414.
22. Fleming CM, Branch RA, Wilkinson GR, Guengerich FP. Human liver microsomal N-hydroxylation of dapsone by cytochrome P-450 3A4. Mol Pharmacol 1992; 41: 975-980.
23. Vage C, Svensson CK. Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P-450 2C6/2C11 and 3A1. Drug Metab Dispos 1994; 22: 572-577.
24. Frederick CB et al. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA. Cancer Res 1982; 42: 2671-2677.
25. Kamataki T et al. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Mol Pharmacol 1983; 24: 146-155.
26. Hammons GJ et al. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res 1985; 45: 3578-3585.
27. PA (P-450 IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-methylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci (USA) 1989; 86: 7696-7700.
28. Butler MA, Guengerich FP, Kadlubar FF. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis (2-chloraniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res 1989; 49: 25-31.
29. Yun Ch, Shimada T, Guengerich FP. Contributions of human liver cytochrome P-450 enzymes to the N-oxidation of 4,4′-methylene-bis (2-chloroaniline). Carcinogenesis 1992; 13: 217-222.
30. Franklin MR. Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmac Ther A 1977; 2: 227-245.
31. 2 (P-450 IIB4): influence on heme liganding of arylamines, Arch Biochem Biophys 1992; 292: 287-294.
32. Hlavica P. Studies on the active site of mixed function oxidases in rabbit liver microsomes. Biochem Biophys Res Commun 1970; 40: 212-217.
33. Hlavica P, Kehl M. Comparative studies on the N-oxidation of aniline and N,N-dimethylaniline by rabbit liver microsomes. Xenobiotica 1976; 6: 679-689.
34. Jänig GR et al. Chemical modification of cytochrome P-450 LM2 with N-acetylimidazole. Evidence for the functional involvement of tyrosyl residues. Biomed Biochim Acta 1985; 44: 1071-1082.
35. Yun CH et al. Modification of cytochrome P-450 1A2 enzymes by mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl. Biochemistry 1992; 31: 10556-10563.
36. Novak RF, Kapetanovic IM, Mieyal JJ. Nuclear magnetic reasonance studies of substratehemoprotein complexes in solution. Mol Pharmacol 1977; 13: 15-30.
37. 5 in the cytochrome P-450-dependent oxygenase system. Arch Biochem Biophys 1984; 228: 600-608.
38. 5-enriched rabbit liver microsomal fractions. Biochim Biophys Acta 1987; 913: 219-227.
39. Estabrook RW et al. The peroxidatic function of liver microsomal cytochrome P-450: comparison of hydrogen peroxide and NADPH-catalyzed N-demethylation reactions. Xenobiotica 1984; 14: 87-104.
40. Andersson B, Larsson R, Rahimtula A, Moldeus P. Hydroperoxide-dependent activation of p-phenetidine catalyzed by prostaglandin synthase and other peroxidases. Biochem Pharmacol 1983; 32: 1045-1050.
41. Lawton MP et al. A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities. Arch Biochem Biophys 1994; 308: 254-257.
42. Ziegler DM. Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 1993; 33: 179-199.
43. Poulsen LL, Masters BSS, Ziegler DM. Mechanism of 2-naphthylamine oxidation catalysed by pig liver microsomes. Xenobiotica 1976; 6: 481-498.
44. Golly I, Hlavica P. The role of haemoglobin in the N-oxidation of 4-chloroaniline. Biochim Biophys Acta 1983; 760: 69-76.
45. Duverger-van Bogaert M, Wiame D, Stecca C. Oxidative activation of 2-aminofluorene by human red blood cell cytosol. Biochem Pharmacol 1992; 44: 2422-2424.
46. Lenk W, Sterzl H. Peroxidase activity of oxyhaemoglobin in vitro. Xenobiotica 1984; 14: 581-588.
47. O'Brien PJ. Multiple mechanisms of metabolic activation of aromatic amine carcinogens. In: Pryor WA (ed.). Free Radicals in Biology, Vol. VI, Academic Press, New York, 1984, pp 289-322.
48. Marnett LJ, Weller P, Battista JR. Comparison of the peroxidase activity of hemeproteins and cytochrome P-450. In: Oritz de Montellano PR (ed.). Cytochrome P-450. Structure, Mechanism, and Biochemistry, Plenum Press, New York, 1986, pp29-76.
49. Castro CE. Mechanisms of reaction of hemoproteins with oxygen and hydroperoxide in the oxidation of organic substrates. Pharmac Ther 1980; 10: 171-189.
50. Ortiz de Montellano PR. Catalytic sites of hemoprotein peroxidases. Annu Rev Pharmacol Toxicol 1992; 32: 89-107.
51. Josephy PD, Eling TE, Mason RP. Oxidation of p-aminophenol catalyzed by horseradish peroxidase and prostaglandin synthase. Mol Pharmacol 1983; 23: 461-466.
52. Chance B. The kinetics and stoichiometry of the transition from the primary to the secondary peroxidase peroxide complexes. Arch Biochem Biophys 1952; 41: 416-424.
53. Thompson DC, Eling TE. Reactive intermediates formed during the peroxidative oxidation of anisidine isomers. Chem Res Toxicol 1991; 4: 474-481.
54. Ross D et al. The oxidation of p-phenetidine by horseradish peroxidase and prostaglandin synthase and the fate of glutathione during such oxidations. Biochem Pharmacol 1985; 34: 343-351.
55. Hughes MF, Smith BL, Eling TE. The oxidation of 4-aminobiphenyl by horseradish peroxidase. Chem Res Toxicol 1992; 5; 340-345.
56. Josephy PD, Eling TE, Mason RP. An electron spin resonance study of the activation of benzidine by peroxidases. Mol Pharmacol 1983; 23: 766-770.
57. Josephy PD, Eling TE, Mason RP. The horseradish peroxidase-catalyzed oxidation of 3,5,3′,5′-tetramethylbenzidine. J Biol Chem 1982; 257: 3669-3675.
58. Huang J, Dunford HB. One-electron oxidative activation of 2-aminofluorene by horseradish peroxidase compounds I and II: spectral kinetic studies. Arch Biochem Biophys 1991; 287: 257-262.
59. Böttcher G, Kiese M. Oxydation von Anilin zu Nitrosobenzol durch Peroxydasen. Naturwissenschaften 1960; 47: 157.
60. Boyd JA, Eling TE. Evidence for a one-electron mechanism of 2-aminofluorene oxidation by prostaglandin H synthase and horseradish peroxidase. J Biol Chem 1984; 259: 13885-13896.
61. Uetrecht J, Zahid N. Procainamide (PA) is N-chlorinated by myeloperoxidase (MPO)-implications for toxicity. Pharmacologist 1988; 30: A98.
62. Uetrecht J, Zahid N, Rubin R. Metabolism of procainamide to a hydroxylamine by human neutrophiles and mononuclear leukocytes. Chem Res Toxicol 1988; 1: 74-78.
63. Cribb AE, Miller M, Tesoro A, Spielberg SP. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophiles from humans and dogs. Mol Pharmacol 1990; 38: 744-751.
64. Uetrecht J, Zahid N, Shear NH, Biggar WD. Metabolism of dapsone to a hydroxylamine by human neutrophiles and mononuclear cells. J Pharmacol Exp Ther 1988; 245: 274-279.
65. Corbett MD, Chipko BR, Batchelor AO. The action of chloride peroxidase on 4-chloroaniline. Biochem J 1980; 187: 893-903.
66. Doerge DR, Corbett MD. Peroxygenation mechanism for chloroperoxidase-catalyzed N-oxidation of arylamines. Chem Res Toxicol 1991; 4: 556-560.
67. Boyd JA, Harvan DJ, Eling TE. The oxidation of 2-aminofluorene by prostaglandin endoperoxide synthetase. J Biol Chem 1983; 258: 8246-8254.
68. Marnett LJ. Hydroperoxidase-dependent oxidations during prostaglandin biosynthesis. In: Pryor WA (ed.). Free Radicals in Biology, Vol. VI, Academic Press, New York, 1984, pp 63-94.
69. Wise RW, Zenser TV, Kadlubar FF, Davis BB. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res 1984; 44: 1893-1897.
70. Josephy PD, Eling TE, Mason RP. Co-oxidation of benzidine by prostaglandin synthase and comparison with the action of horseradish peroxidase. J Biol Chem 1983; 258: 5561-5569.
71. Zenser TV et al. Prostaglandin H synthase catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis. J Pharmacol Exp Ther 1983; 227: 545-550.
72. Golly I, Hlavica P. N-Oxidation of 4-chloroaniline by prostaglandin synthase. Biochem J 1985; 226: 803-809.
73. Kadlubar FF, Frederick CB, Weis CC, Zenser TV. Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem Biophys Res Commun 1982; 108: 253-258.
74. Munday R. Generation of superoxide radical and hydrogen peroxide by 1,2,4-triaminobenzene, a mutagenic and myotoxic aromatic amine. Chem-Biol Interact 1986; 60: 171-181.
75. Chignell CF, Kalyanaraman B, Mason RP, Sik RH. Spectroscopic studies of cutaneous photosensitizing agents - I. Spin trapping of photolysis products from sulfanilamide, 4-aminobenzoic acid and related compounds. Photochem Photobiol 1980; 32: 563-571.
76. Sanniez WHK, Pilpel N. Photodecomposition of sulfonamides and tetracyclines. J Pharm Sci 1980; 69: 5-8.
77. Reisch J, Niemeyer DH. Photo- and radiation chemical studies. XIV. Photochemical studies of sulfanilamide, sulfacetamide and ethyl-4-aminobenzoate. Arch Pharm 1972; 305: 135-140.
78. Okinaka RT, Nikols JW, Whaley TW, Strniste GF. Phototransformation of 2-aminofluorene into N-oxidized mutagens. Carcinogenesis 1984; 5: 1741-1743.
79. Golly I, Hlavica P, Wolf J. The role of lipid perodixation in the N-oxidation of 4-chloroaniline. Biochem J 1984; 224: 415-421.
80. Sabourin P et al. Distribution of microsomal monooxygenases in the rabbit respiratory tract. Drug Metab Dispos 1988; 16: 557-562.
81. Hoffman D, Masuda X, Wynder EL. α-Naphthylamine and β-naphthylamine in cigarette smoke. Nature 1969; 221: 254-256.